RxRevu, an industry leader in Prescription Decision Support, has closed its Series B funding round, raising $7 million, bringing the total investment in the company to $28 million.

The investment round was led by JAZZ Venture Partners, with additional investments from existing strategic health system partners.

RxRevu is on a mission to improve healthcare by providing accurate, patient-specific coverage and cost data at the point-of-care. RxRevu's solutions help physicians quickly and easily find affordable care options specific to a patient's health and financial needs. RxRevu's solutions also enable health systems to manage and measure clinician's performance and variability.